# Standardized sTudy With Almotriptan in eaRly Treatment of Migraine

> **NCT00725140** · — · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 501 (actual)

## Conditions studied

- Migraine

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00725140
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-04
- **Final completion:** 2009-07
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2015-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00725140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00725140, "Standardized sTudy With Almotriptan in eaRly Treatment of Migraine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00725140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*